Overview Request Sample Pages Request Customization Download PDF
You are viewing: China Gastrointestinal Stent Market analysis
Part of: Gastrointestinal Stent Market (Global)

The China Gastrointestinal Stent Market was valued at $52.88 Million in 2026 and projected to reach to $79.65 Million by 2031, representing a compound annual growth rate of 8.5%. China's gastrointestinal stent market is positioned for sustained growth through 2031, supported by demographic shifts, increased healthcare spending, and rising awareness of minimally invasive treatment options.

China Gastrointestinal Stent Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Gastrointestinal Stent Market Trends and Insights

  • China's market growth rate of 8.5% CAGR significantly outpaces the global average of 5.7%, reflecting strong demand driven by an aging population and rising prevalence of gastrointestinal disorders.
  • China's healthcare infrastructure modernization and increased adoption of minimally invasive procedures are accelerating stent utilization across urban and emerging markets. The Chinese market benefits from government healthcare reforms and expanded insurance coverage that improve patient access to advanced therapeutic devices.
  • China's growing middle class and rising healthcare expenditure are fueling demand for both metallic and polymer-based stents.
  • By 2031, China is expected to consolidate its position as a key growth engine within the Asia Pacific region, with domestic manufacturers increasingly competing alongside international players to capture market share..

Key Market Statistics

  • CAGR (2026-2031) 8.5% CAGR
  • Market Size, 2026 ~USD 52.88 Million
  • Forecast, 2031 ~USD 79.65 Million
  • Country China

China Gastrointestinal Stent Market Overview

Rapid Market Expansion :

China's gastrointestinal stent market is growing at 8.5% CAGR, significantly outpacing the global average of 5.7%, driven by increasing healthcare investments and rising disease prevalence.

Aging Population Dynamics :

China's rapidly aging demographic is driving demand for gastrointestinal interventions, with the elderly population more susceptible to esophageal, biliary, and colorectal conditions requiring stent placement.

Healthcare Infrastructure Modernization :

Substantial investments in hospital infrastructure, endoscopic capabilities, and medical device adoption across tier-1, tier-2, and tier-3 cities are expanding market accessibility and procedure volumes.

Market Valuation Growth :

The market is valued at USD 52.88 million in 2026 and projected to reach USD 79.65 million by 2031, representing a 50.6% increase over the five-year forecast period.

China Gastrointestinal Stent Market Dynamics

  • The country's expanding middle class and improved insurance coverage are enabling greater patient access to advanced endoscopic procedures.
  • Government initiatives promoting healthcare modernization and the integration of international medical standards are accelerating adoption of premium stent technologies.
  • Additionally, growing prevalence of gastrointestinal cancers and benign strictures continues to fuel procedural demand across urban and emerging markets..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • China's gastrointestinal stent market is valued at USD 52.88 million in 2026 and will grow to USD 79.65 million by 2031, representing 50.6% total growth.
    • China's 8.5% CAGR substantially exceeds the global rate of 5.7%, positioning China as the fastest-growing major market in the sector.
    • China's aging demographic and rising gastrointestinal disease prevalence are primary drivers of increased stent adoption and procedure volumes.
    • China's expanding healthcare infrastructure and government-backed insurance initiatives are democratizing access to advanced stent technologies across tier-2 and tier-3 cities.

    Gastrointestinal Stent Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment BIODEGRADABLE STENTS (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 5.7% from 2026 to 2031
    Largest Segment HOSPITALS & CLINICS (End User)
    Market Size Base Year (Billions) ~USD 0.62 (2026)
    Revenue Forecast (Billions) ~USD 0.82 (2031)
    Segments Covered Product, Type, Mechanism, Coverage, Application, End User

    China Gastrointestinal Stent Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Duodenal Stents
    • Esophageal Stents
    • Metal Stents
    • Pancreatic Stents
    • Plastic Stents

    By Type

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Colorectal Cancer
    • Duodenal Stents
    • Esophageal Cancer
    • Esophageal Stents
    • Magnesium-Based Stents
    • Metal Stents
    • Nitinol Stents
    • Other Biodegradable Stents
    • Other Metal Stents
    • Pancreatic Cancer
    • Pancreatic Stents
    • Plastic Stents
    • Polymer-Based Stents
    • Stainless Steel Stents
    • Stomach Cancer

    By Mechanism

    • Balloon-Expandable Metal Stents (Bems)
    • Self-Expanding Metal Stents (Sems)

    By Coverage

    • Fully Covered Stents
    • Partially Covered Stents
    • Uncovered Stents

    By Application

    • Benign Strictures & Leaks
    • Biliary Disease
    • Biliary Diseases
    • Gastrointestinal Cancer
    • Other Applications

    By End User

    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Specialty Endoscopy Centers/Gi Clinics

    CHINA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    AMBULATORY SURGICAL CENTERS5.35.86.36.87.58.18.99.79.1
    HOSPITALS & CLINICS30.132.535.137.940.944.348528.2
    SPECIALTY ENDOSCOPY CENTERS/GI CLINICS9.710.611.512.613.71516.417.99.2
    TOTAL45.248.852.957.362.167.473.279.68.5

    Target Audience

    • Medical Device Manufacturers : Stent manufacturers and medical device companies need China-specific market data to assess market entry opportunities, competitive positioning, and revenue forecasting in Asia's largest healthcare market.
    • Healthcare Investors & PE Firms : Investment professionals require detailed China market analysis to evaluate portfolio opportunities, identify acquisition targets, and assess growth potential in the high-performing gastrointestinal device sector.
    • Hospital & Healthcare Providers : Hospital administrators and procurement teams need market insights to optimize inventory planning, negotiate supplier contracts, and understand demand trends for gastrointestinal interventions.
    • Market Consultants & Strategists : Business consultants and strategy firms require China-focused market intelligence to support client advisory work, competitive analysis, and market entry strategy development.
    • Regulatory & Compliance Officers : Regulatory professionals need China market data to understand local approval pathways, reimbursement policies, and compliance requirements for gastrointestinal stent commercialization.

    Key Companies in the China Gastrointestinal Stent Market

    CompanyHQOwnershipStrongest segments
    ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation services and lifecycle support,Contract manufacturing and integration services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (coronary, structural heart, CRM, peripheral),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg – Urology and Pelvic Health,
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopes & Integrated OR Solutions,Advanced Energy Devices,
    M.I. TECHMalaysiaPublic CompanyDie sorting and smart binning equipment,Test handling and vision inspection equipment,Laser bonding and precision bonding equipment,
    MICRO-TECH (NANJING) CO., LTD.ChinaPublic CompanyDigestive endoscopy – ESD and ERCP (therapeutic devices and accessories),Stents and dilation/biopsy systems (biliary, intestinal, esophageal),Hemostasis, EUS, and diagnostic accessories,
    MERIT MEDICAL SYSTEMSUnited StatesPublic CompanyCardiovascular access and intervention (micropuncture, sheaths, guidewires, angiography, hemostasis),Peripheral intervention and embolotherapy (angiography, drainage, delivery, embolic solutions),Oncology and spine (soft tissue biopsy, vertebral augmentation, RF ablation, bone biopsy),
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
    STERISIrelandPublic CompanyHealthcare sterilization, decontamination, and OR infrastructure,Applied Sterilization Technologies (outsourced sterilization services),Life sciences contamination control and processing,
    BDUnited StatesPublic CompanyMedical Essentials (IV access, syringes, needles, sharps, vascular care),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    Q3 MEDICAL GROUPIrelandPrivate CompanySpecialty procedures and interventions,Outpatient and ambulatory services,Diagnostics and imaging,
    BVMTunisiaPublic CompanyFire, miscellaneous accidents, and engineering,Marine, energy, and aviation (including pools),Agricultural and emerging risks,

    ATS AUTOMATION TOOLING SYSTEMS INC

    ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company operates in the medical device and healthcare sectors.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates across imaging, medical, and industrial technology sectors.

    M.I. TECH

    M.I. Tech is a Malaysian public company founded in 2007 with 594 employees. The company operates in the technology sector.

    MICRO-TECH (NANJING) CO., LTD.

    Micro-Tech (Nanjing) Co., Ltd. is a Chinese public company founded in 2000 with 2,433 employees. The company operates in the medical device industry.

    MERIT MEDICAL SYSTEMS

    Merit Medical Systems is a United States-based public company founded in 1987 with 7,500 employees. The company manufactures and distributes medical devices and supplies.

    MEDTRONIC

    Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

    STERIS

    STERIS is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and industrial markets.

    BD

    BD is a United States-based public company founded in 1897 with 72,000 employees. The company is a global medical technology company specializing in medical devices, diagnostics, and biosciences.

    Q3 MEDICAL GROUP

    Q3 Medical Group is an Ireland-based private company founded in 2013. The company operates in the medical device or healthcare sector.

    BVM

    BVM is a Tunisia-based public company founded in 1981 with 99 employees. The company operates in the medical or industrial sector.

    Reasons to Buy this Report

    • Outperforming Growth Metrics : Gain insights into China's 8.5% CAGR market expansion, which significantly exceeds global benchmarks, enabling strategic positioning in the fastest-growing major gastrointestinal stent market.
    • Demographic-Driven Opportunity Analysis : Understand how China's aging population and rising gastrointestinal disease prevalence create sustained demand for stent procedures, informing long-term market entry and expansion strategies.
    • Infrastructure Investment Intelligence : Access detailed analysis of China's healthcare modernization initiatives, hospital capacity expansion, and endoscopic procedure growth across geographic tiers to identify high-potential market segments.
    • Competitive Landscape Clarity : Develop market-specific competitive strategies by understanding China's unique regulatory environment, reimbursement structures, and local manufacturer dynamics versus international players.
    • Forecast-Driven Planning : Leverage precise market projections (USD 79.65M by 2031) to guide product development, manufacturing capacity planning, and distribution network investments in China's high-growth market.

    Frequently asked questions

    What is the current size of China's gastrointestinal stent market?

    China's gastrointestinal stent market is valued at USD 52.88 million in 2026 and is projected to reach USD 79.65 million by 2031.

    What is China's market growth rate for gastrointestinal stents?

    China's gastrointestinal stent market is growing at a CAGR of 8.5% from 2026 to 2031, significantly higher than the global average of 5.7%.

    What factors are driving growth in China's gastrointestinal stent market?

    Key drivers include China's aging population, rising prevalence of gastrointestinal disorders, healthcare infrastructure modernization, expanded insurance coverage, and increased adoption of minimally invasive procedures.

    How does China's market performance compare to global trends?

    China's 8.5% CAGR substantially outpaces the global CAGR of 5.7%, making China one of the fastest-growing markets for gastrointestinal stents worldwide.

    What is the expected market value of China's gastrointestinal stent market by 2031?

    China's gastrointestinal stent market is forecast to reach USD 79.65 million by 2031, representing approximately 50.6% growth from the 2026 baseline.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

    A breakdown of the primary respondents is provided below:

    Gastrointestinal Stent Market Size, and Share

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

    Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

    Gastrointestinal Stent Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

    Market Definition

    The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

    Key Stakeholders

    • GI stent manufacturers (metal, plastic, biodegradable stents)
    • Endoscopy device & delivery system manufacturers
    • Raw material & component suppliers (metals, polymers, coatings)
    • Hospitals & ambulatory surgical centers (public & private)
    • Gastroenterology clinics & endoscopy centers
    • Gastroenterologists, interventional endoscopists & GI surgeons
    • Contract manufacturers & OEM partners
    • Distributors & regional channel partners
    • Academic & clinical research institutions
    • Regulatory authorities & healthcare agencies
    • Market research & consulting firms
    • Investors & private equity firms

    Report Objectives

    • To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Customization Options:

    With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

    Competitive Landscape Assessment

    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
    • Competitive leadership mapping for established players in the US

    Get the Full Gastrointestinal Stent Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Stent Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status